The test of your character is what it takes to stop you!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another bad day for Tesla $TSLA as shares fall to lowest since early April. Goldman Sachs on Thurs reiterated sell rating. https://t.co/x5jX36UupK
Going forward, #Tesla may find a new way to approach car launches based on mass market growth, read here: https://t.co/VjFkzrFJo5 $TSLA #TeslaMotors #ElectricVehicle #ElonMusk
$TSLA soon to be $TSLAQ. Penny stock in the making.
A $TSLA stock price of $275 implies a possible 1/2 billion dollar shortfall in Elon's pledged stock vs loan value.
Would result in his having to pledge an additional 1.82 million shares.
Would mean that 9.2% of $TSLA's total O/S stock would be pledged for Elon's personal loans
$GTBP have been resistance the past few days, perhaps investors have a high degree of confidence in the upcoming financial sector earning reports and indirectly benefitting the healthcare sector, particularly the biotech sub-sector. Keeping my eyes peeled, GTBP for next week...
They are very high level professionals...$GTBP
$GTBP has Approved FDA IND Transfer of Its First TriKE (OXS-3550) http://biotechstocks.com/gt-biopharma-inc-gtbp-announces-approved-fda-ind-transfer-of-its-first-trike-oxs-3550/ … via @Biotech Stocks
IMO the real value in this company is in OXS-3550 $GTBP...
OXS-3550 TriKE has been proven to superior to OXS-1550 in in vivo studies, so I don't expect OXS-1550 to pass Phase II trials, however OXS-3550 TriKE most likely will. As it has been proven to be more effective than Rituxan in killing cancer cells.
OXS-3550 TRiKe looks even more promising than OXS-1550
http://bispecific.com/wp-content/uploads/sites/90/2016/10/Vallera-TRiKEs.pdf
https://ash.confex.com/ash/2016/webprogram/Paper93724.html
http://stm.sciencemag.org/content/8/328/328ec35
I'm deeply shocked to read this! Cancer has a major impact on society in the United States and across the world. Based on statistic In 2017, an estimated 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease.
But behind these huge problems, there's huge opportunity as well for $GTBP
PROVEN TRACK RECORD MANAGEMENT! Dr. Urbanski (Pfizer) and Dr. Clarence-Smith (Sanofi) $GTBP TO THE MOON!!! $GTBP
That interview is SOOO REAL!!! Thanks for sharing, NYC! Very informative.
They have been fighting to break that $1.70 range and with the volume they been having IMO its only a matter of time before GTBP decides to run into $2 once again
$GTBP therapy pipeline should hit some significant milestones in 2018. Great for investors
$GTBP $1.60 up green. Great start to a potentially very good friday!!!
Immuno-oncology is the next big thing for big pharma! Now, biopharmaceutical companies such as $GTBP are making dramatic advances in an emerging area of research known as immuno-oncology. This marks a significant milestone in the battle against cancer. As the name implies, immuno-oncology marshals the human body’s own immune system to fight cancer. In many cases, immunotherapy is vastly preferable to conventional treatments. Survival rates are higher in several tumor types, and these medications have the potential to significantly extend lives. Treatments also can be deployed against a wide array of cancers. I believe immuno-oncology holds enormous promise for patients and significant opportunities for investors.
Well said NYC! Immuno Oncology is to cancer what smart bombs are to terrorists. It drops a Hellfire missile in the bad guy's lap without damaging the school next door. No collateral damage. The therapy can be calibrated to go only after the cancer cells or cancer stem cells, without damaging healthy cells. It can harness the bodies own "killer cells" to go after cancer cells and deliver deadly "payloads" to those malignant cells alone. This is a huge win not only against cancer, but for the dignity and quality of human life in the midst of medical treatment. It is not just a medicine, it is a victory for humanity. $GTBP
Here's my recap from the $GTBP CC: They built an all-star management team with big pharma experience which is huge for the company's future!
SURE! So much going for GTBP right now for this to be under 1.60s. BUT I think there's a long term potential bullish $1.70 and above with just new update OXS-3550 IND Filing alone in consideration.
Good morning $GTBP friends
Agreed. GTBP has way too much going on right now to ignore it...especially with the way companies are now promoting Dr. Urbanski to be President and Chief Medical Officer of the Company and update OXS-3550 IND Filing. Recovery is on the way!
In other words it will recover by OXS-3550 .haha!
Great materials for all the new investors here
Yes OF COURSE!!! Expecting an epic bounce next week from these levels upwards. $GTBP
So much going for GTBP right now for this to be under 1.60s. BUT I think there's a long term potential bullish with just the new executive board alone in consideration.
$GTBP with strong Leadership, Dr.Urbanksi (President & CMO).
I believe that we are in a golden age of research and development in the biopharmaceutical industry. Cutting-edge discoveries are being made in a number of areas, and immuno-oncology is one of the most promising. It has the potential to extend patient lives by many years – in effect, coming as close as science has ever been to finding a “cure” for cancer. In the next few years, I expect a number of companies started to join GT Bio Pharma to introduce immune-based medications. After that, attention will turn to determining which drug combinations are the most effective against specific cancers. That will be an essential step in boosting long-term survival rates. $GTBP
$GTBP The depth and experience of the leadership team here is a very telling indicator of where GT Biopharma is heading. "Look at Where Deutsche Bank’s Shawn Cross, Pfizer’s Dr. Raymond Urbanski, Chase Pharmaceutical’s Dr. Kathleen Clarence-Smith, and Barker Davis Founder Geoffrey Davis are making their bets. Some of the biotech sector’s most affluent and influential individuals are making a move... to GT Biopharma Inc. (GTBP). This up-and-coming biotech company has a therapy pipeline that has attracted some of the industry’s most experienced leaders."
IMHO GT Biopharma soon will turn into a leading player in the biotechnology industry. I expect this 2018 to be a similarly productive year as compared to 2017 but with more of an emphasis on creating shareholder value by hitting our clinical and pre-clinical milestones vs reducing debt and recruiting management. I' pretty sure $GTBP will be listed on NASDAQ and will appoint additional experienced employees and board members.
People are always searching for an OTC that can uplist to NASDAQ. Well, here it is $GTBP. Waiting currently on NASDAQ approval and then see what happens.
Top 3 Biggest Biotech Stock Movers In Early Second Quarter
https://medium.com/stock-market-source/top-3-biggest-biotech-stock-movers-in-early-second-quarter-c14458909e2f
Long $GTBP!!!!
Immuno-oncology, one of the pillars of cancer treatment, is driving engagement worldwide among biotech, large pharma, universities/cancer centers and the financial investment community. Currently, more than 130 biotech and 20 pharma companies are developing immuno-oncology therapies and GT Biopharma is one of a leading pharma company! $GTBP
I like this stock, at least you don't see a huge nasty drop. Like most of the OTCs and these guys have real product. Trading nice and level, stable.
ADAC agressive innovative inteligent management, love it
It's down red 2,5% again but $GTBP had a great DD imho it's only a matter of time till we see GTBP on the big board's. Waiting for rebound 1.60s . Looking for 2.00 by end of the month.
I agree BC! Volume this last week for GTBP has been consistently increasing IMO its only a matter of time before the price follows the same pattern and starts to increase as well...just a waiting game at this point
Its good to have GREEN $1.62 UP 1.89%.
GTBP looking solid this morning, my eyes are on this one, look good and GTBPs news out about Dr.Urbanski elevation & OXS-3550 IND Filing make this stock even better.
Dr. Daniel Vallera, the inventor of OXS-1550 and Director of the Section on Molecular Cancer Therapeutics at the University of Minnesota Masonic Cancer Center, said he believes OXS-1550 will play an important role in the treatment of cancer. The drug is designed to identify certain cancer cells and kill them, without damaging healthy cells.
"We believe OXS-1550 to be a powerful alternative to existing chemotherapies, since many patients fail chemotherapy or reach the toxic limits of their therapy," Vallera said.
NOW we have seen the benefit of OXS-1550